Dymista: new combination intranasal rhinitis treatment
The nasal spray Dymista is now available for the treatment of perennial...
Jump to:
The latest innovation from GP magazine to make your life easier: a new medical supplies portal bringing you more than 60,000 essential products.
www.GPsupermarket.com
Lyxumia (lixisenatide) is a once-daily parenteral hypoglycaemic for the management of uncontrolled...
The nasal spray Dymista is now available for the treatment of perennial...
The General Medical Council (GMC) has published new guidance for all doctors...
Perjeta (pertuzumab) is licensed for HER2-positive metastatic or locally recurrent unresectable breast...
Zaltrap (aflibercept) is licensed for the treatment of metastatic colorectal cancer that...
Zoely is the first combined oral contraceptive to use nomegestrol as its...
Other new launches, licence changes and prescribing updates relevant to general practice.
Following a review, NICE have overturned their previous negative decision for abatacept...
Omalizumab (Xolair) has been accepted by NICE for broader use in the...
Patients with idiopathic pulmonary fibrosis can now benefit from the novel treatment...
Elvanse (lisdexamfetamine) is a long-acting pro-drug stimulant indicated for the treatment of...
Almirall has launched Constella (linaclotide) for the symptomatic treatment of moderate to...
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.
Supplied by the National
Travel Health Network
and Centre (NaTHNaC)